Mary K. Olson : Citation Profile


Are you Mary K. Olson?

Tulane University

6

H index

2

i10 index

62

Citations

RESEARCH PRODUCTION:

12

Articles

1

Papers

RESEARCH ACTIVITY:

   26 years (1992 - 2018). See details.
   Cites by year: 2
   Journals where Mary K. Olson has often published
   Relations with other researchers
   Recent citing documents: 4.    Total self citations: 7 (10.14 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pol152
   Updated: 2020-10-24    RAS profile: 2019-12-02    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Mary K. Olson.

Is cited by:

Sun, Eric (3)

Söderberg, Magnus (3)

Philipson, Tomas (3)

Law, Marc (2)

Salin, Victoria (2)

Earnhart, Dietrich (2)

Markowitz, Sara (2)

Richards-Shubik, Seth (2)

Hooker, Neal (2)

Michael, Bryane (1)

Kuhn, Michael (1)

Cites to:

peltzman, sam (5)

Kyle, Margaret (3)

Philipson, Tomas (2)

Linn, Joshua (2)

Weingast, Barry (2)

Acemoglu, Daron (2)

Sun, Eric (2)

Joskow, Paul (2)

Markowitz, Sara (1)

Williams, Heidi (1)

Dranove, David (1)

Main data


Where Mary K. Olson has published?


Journals with more than one article published# docs
Journal of Law, Economics, and Organization3
Journal of Health Economics2
Journal of Economics & Management Strategy2

Recent works citing Mary K. Olson (2020 and 2019)


YearTitle of citing document
2020Regulating Innovation with Uncertain Quality: Information, Risk, and Access in Medical Devices. (2020). Town, Robert J ; Grennan, Matthew. In: American Economic Review. RePEc:aea:aecrev:v:110:y:2020:i:1:p:120-61.

Full description at Econpapers || Download paper

2019Who cares about a label? The effect of pediatric labeling changes on prescription drug utilization. (2019). Schmitt, Matt ; Ody, Christopher. In: International Journal of Health Economics and Management. RePEc:kap:ijhcfe:v:19:y:2019:i:3:d:10.1007_s10754-019-09265-y.

Full description at Econpapers || Download paper

2020The impact of regulatory review time on incremental and radical innovation: evidence from the high-risk medical device market. (2020). Soderberg, Magnus ; Onur, Ilke. In: Journal of Regulatory Economics. RePEc:kap:regeco:v:57:y:2020:i:2:d:10.1007_s11149-020-09401-4.

Full description at Econpapers || Download paper

2020For Safety or Profit? How Science Serves the Strategic Interests of Private Actors. (2020). Perlman, Rebecca L. In: American Journal of Political Science. RePEc:wly:amposc:v:64:y:2020:i:2:p:293-308.

Full description at Econpapers || Download paper

Works by Mary K. Olson:


YearTitleTypeCited
1997Firm Characteristics and the Speed of FDA Approval In: Journal of Economics & Management Strategy.
[Full Text][Citation analysis]
article10
2000Regulatory Reform and Bureaucratic Responsiveness to Firms: the Impact of User Fees in the FDA In: Journal of Economics & Management Strategy.
[Full Text][Citation analysis]
article1
2004Are novel drugs more risky for patients than less novel drugs? In: Journal of Health Economics.
[Full Text][Citation analysis]
article10
2008The risk we bear: The effects of review speed and industry user fees on new drug safety In: Journal of Health Economics.
[Full Text][Citation analysis]
article8
1992Pharmaceutical Expenditure and Regulatory Policy in the NHS. In: Washington St. Louis - School of Business and Political Economy.
[Citation analysis]
paper0
2013Eliminating the U.S. drug lag: Implications for drug safety In: Journal of Risk and Uncertainty.
[Full Text][Citation analysis]
article1
1994Political Influence and Regulatory Policy: The 1984 Drug Legislation. In: Economic Inquiry.
[Citation analysis]
article1
1995Regulatory Agency Discretion among Competing Industries: Inside the FDA. In: Journal of Law, Economics, and Organization.
[Citation analysis]
article8
1996Substitution in Regulatory Agencies: FDA Enforcement Alternatives. In: Journal of Law, Economics, and Organization.
[Citation analysis]
article6
1999Agency Rulemaking, Political Influences, Regulation, and Industry Compliance. In: Journal of Law, Economics, and Organization.
[Citation analysis]
article7
1995The Effects of UK Pharmaceutical Policy on Government Drug Expenditure: Cost Control and Incentives for R&D In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
article1
2018Examining Firm Responses to R&D Policy: An Analysis of Pediatric Exclusivity In: American Journal of Health Economics.
[Full Text][Citation analysis]
article1
2002Pharmaceutical Policy Change and the Safety of New Drugs In: Journal of Law and Economics.
[Full Text][Citation analysis]
article8

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2020. Contact: CitEc Team